Note: Ingredients listed on restricted chemical lists
EC/CAS
202-318-7/94-26-8
Name of the chemical
Butyl 4-hydroxybenzoate
Concentration
<0.1
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
0.5%< >=5% <5% 0.5%<
EC/CAS
231-595-7/7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
<25% 017-002- >=25% <25% >=10%
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
EC/CAS
234-394-2/11138-66-2
Name of the chemical
xanthan gum
Concentration
<1
EC/CAS
231-545-4/7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
N/A
EC/CAS
259-952-2/99-76-3
Name of the chemical
4-hydroxybenzoic acid, methyl ester
Concentration
0.1-0.5
EC/CAS
202-785-7
Name of the chemical
4-Hydroxybenzoic acid and its Methyl- and Ethyl-esters, and their salts
Concentration
N/A
General Information
Version
5.01
Revision date
2026-02-16
Product name
Abrocitinib Oral Suspension
Product name
Abrocitinib Oral Suspension
Identification on the label/Trade name
Not applicable
Chemical name
Not determined
1.2.1 Relevant identified uses
Pharmaceutical product
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361fd, H412
Hazard statements
Code
Statements
H361fd
Suspected of damaging fertility; Suspected of damaging the unborn child
Section 2
SECTION 2: Hazards identification
OSHA Classification of the substance or mixture
2.3 Other hazards
Not applicable (HNOC) An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8). Abrocitinib (PF-04965842) Pfizer OEL TWA-8 Hr: Sodium phosphate, dibasic 60 µg/m3 Pfizer Occupational Exposure Band (OEB): PBT & vPvB OEB 1 (control exposure to the range of 1000ug/m3 to 3000ug/m3) The product does not contain any substance(s) classified as PBT or vPvB. Endocrine Disruptor Information Chemical name Contains a known or suspected endocrine disruptor.
Signal word
Warning
Hazard statements
H361fd - Suspected of damaging fertility. Suspected of damaging the unborn child H412 - Harmful to aquatic life with long lasting effects
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P273 - Avoid release to the environment P280 - Wear protective gloves and protective clothing P308 + P313 - IF exposed or concerned: Get medical advice/attention P405 - Store locked up P501 - Dispose of contents/container in accordance with local, regional, national, and international regulations as applicable
Supplemental label elements
Compound, not fully tested, additional hazards may exist. 1 % of the mixture consists of ingredient(s) of unknown acute oral toxicity. 1 % of the mixture consists of ingredient(s) of unknown acute dermal toxicity. 1 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (dust/mist). 1 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (gas). 1 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (vapor). Unknown aquatic toxicity Contains 0 % of components with unknown hazards to the aquatic environment.
2.1 Classification of the substance or mixture
GHS - Classification: Regulated according to Regulation (EC) 1272/2008 and/or other applicable regulations. Reproductive toxicity Category 2 - (H361fd) Hazardous to the aquatic environment - chronic Category 3 - (H412) OSHA Classification Hazards not otherwise classified (HNOC) Not applicable Hazards classified under paragraph (d)(1)(ii) of 1910.1200 Not applicable
